4.1 Review

Alzheimer's Disease and mild cognitive impairment

Journal

NEUROLOGIC CLINICS
Volume 25, Issue 3, Pages 577-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ncl.2007.03.008

Keywords

-

Funding

  1. NIA NIH HHS [U01 AG006786-23, U01 AG006786, P50 AG016574, P50 AG016574-10] Funding Source: Medline

Ask authors/readers for more resources

As our society ages, age-related diseases assume increasing prominence as both personal and public health concerns. Disorders of cognition are particularly important in both regards, and Alzheimer's disease is by far the most common cause of dementia of aging. In 2000, the prevalence of Alzheimer's disease in the United States was estimated to be 4.5 million individuals, and this number has been projected to increase to 14 million by 2050. Although not an inevitable consequence of aging, these numbers speak to the dramatic scope of its impact. This article focuses on Alzheimer's disease and the milder degrees of cognitive impairment that may precede the clinical diagnosis of probable Alzheimer's disease, such as mild cognitive impairment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available